325 related articles for article (PubMed ID: 25162671)
1. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Xu Y; Meng H
Artif Cells Nanomed Biotechnol; 2016; 44(1):350-5. PubMed ID: 25162671
[TBL] [Abstract][Full Text] [Related]
2. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
[TBL] [Abstract][Full Text] [Related]
3. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
[TBL] [Abstract][Full Text] [Related]
4. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
[TBL] [Abstract][Full Text] [Related]
5. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
Dhanikula AB; Singh DR; Panchagnula R
Curr Drug Deliv; 2005 Jan; 2(1):35-44. PubMed ID: 16305406
[TBL] [Abstract][Full Text] [Related]
8. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
[TBL] [Abstract][Full Text] [Related]
9. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
[TBL] [Abstract][Full Text] [Related]
10. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.
Wang F; Zhang D; Zhang Q; Guo S; Zheng D; Hao L; Guo H; Li C
J Drug Target; 2013 Feb; 21(2):137-45. PubMed ID: 23046502
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.
Wang Y; Li Y; Zhang L; Fang X
Arch Pharm Res; 2008 Apr; 31(4):530-8. PubMed ID: 18449513
[TBL] [Abstract][Full Text] [Related]
13. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
14. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
15. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
16. Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection.
Xu Y; Asghar S; Li H; Chen M; Su Z; Xu Y; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2016 Jun; 142():81-88. PubMed ID: 26938323
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
Han LM; Guo J; Zhang LJ; Wang QS; Fang XL
Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers.
Wang Y; Li Y; Wang Q; Fang X
Pharmazie; 2008 Jun; 63(6):446-52. PubMed ID: 18604988
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
